Clinical and payer strategies should treat GLP‑1 therapy as chronic for high-risk patients, addressing tolerability and cost ...

Life’s Essential 8 (LE8) and Life’s Crucial 9 (LC9) from the American Heart Association are industry-accepted metrics that summarize overall cardiovascular health. A new study documented inverse ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in patients with Type 2 diabetes.

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a yearlong campaign to stop independent labs from producing cheaper versions.

It's 'definitely not a measure of fatness,' and it doesn't accurately define what it means to be overweight. Body mass index isn't always the best predictor of health. In the age of weight-loss drugs, ...

The lowered pricing structure is now available for 101.82 EUR per bottle at pharmacies throughout Finland AMSTERDAM, March 18, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharma ...

Epigenetic programming from prolonged undernutrition and terror can persist 3–4 generations, plausibly contributing to elevated cardiometabolic and mental health burdens documented among Irish cohorts ...

Nearly 1 in 5 teens in the United States is obese, putting their long-term health at serious risk. Obesity in adolescence ...

While overall life expectancy in the US has improved slightly in the last couple of years, that could change as these ...